Qing-Liang Guo
Overview
Explore the profile of Qing-Liang Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng D, Di L, Guo Q, Ding J, Zhao X, Lu S
Can J Gastroenterol Hepatol
. 2021 Jan;
2020:8893119.
PMID: 33415086
Objective: To investigate the effect of splenectomy for correction of systemic hemodynamic disorders in hepatic cirrhosis patients with portal hypertension. Methods: Hepatic cirrhosis patients with portal hypertension were enrolled from...
2.
Zhao X, Lin D, Li N, Wu J, Guo Q, Wang L
Transpl Immunol
. 2020 Jun;
62:101307.
PMID: 32540505
Objective: This study aims to summarize a clinical experience on the diagnosis and treatment of acute graft-versus-host disease (aGVHD) after liver transplantation. Methods: Between April 2005 and August 2016, 11...
3.
Duan B, Tian L, Lin D, Zhang J, Guo Q, Wu J, et al.
J Viral Hepat
. 2019 Aug;
26 Suppl 1:85-89.
PMID: 31380589
Background: The long-term administration of nucleotide analogues (NAs) and hepatitis B immune globulin (HBIG) comprises standard prophylaxis for patients with hepatitis B virus (HBV)-related liver diseases to prevent HBV reinfection...
4.
Zeng D, Di L, Zhang R, Guo Q, Duan B, Jia C, et al.
Gastroenterol Res Pract
. 2019 May;
2019:5459427.
PMID: 31093275
Background: Studies have demonstrated that liver fibrosis can be reversed by medication treatments. After splenectomy, cirrhosis patients have short-term changes in several serum markers for cirrhosis and liver stiffness. Aims:...
5.
Li C, Lu S, Lai W, Liu Y, Zeng T, Guo Q, et al.
Zhonghua Wai Ke Za Zhi
. 2013 Nov;
51(8):691-5.
PMID: 24252673
Objective: To investigate the pathogenesis of ischemic-type biliary lesions (ITBLs) in post-liver transplant patients and the possible therapeutic mechanisms of sirolimus. Methods: The clinic data of 32 post-liver transplant patients...
6.
Duan B, Lu S, Wang M, Liu J, Chi P, Lai W, et al.
J Surg Res
. 2013 Apr;
183(2):936-43.
PMID: 23558257
Background: Acute-on-chronic liver failure (ACLF) is a severe clinical condition for which liver transplantation (LT) is the only curative option. However, there are little published data on risk factors and...
7.
Lai W, Lu S, Li G, Li C, Wu J, Guo Q, et al.
World J Gastroenterol
. 2012 Jul;
18(26):3443-50.
PMID: 22807615
Aim: To compare the incidence of early portal or splenic vein thrombosis (PSVT) in patients treated with irregular and regular anticoagulantion after splenectomy with gastroesophageal devascularization. Methods: We retrospectively analyzed...
8.
Wu J, Lu S, Wang M, Xia R, Guo Q, Gao D, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
. 2009 May;
22(5):367-9.
PMID: 19469177
Objective: To summarize the clinical data in preventing HBV recurrence after liver transplantation and explore a optimal individual protocol in prophylaxis of HBV recurrence. Methods: We retrospected outcomes in 195...
9.
Lu S, Dai J, Wang M, Zhang Z, Lai W, Wu J, et al.
Zhonghua Wai Ke Za Zhi
. 2008 Dec;
46(19):1453-6.
PMID: 19094619
Objective: To research the clinical feasibility of emergency right lobe adult-to-adult live-donor liver transplantation in treating acute liver failure following severe hepatitis. Methods: Consecutive ten severe hepatitis patients (4 acute-on-chronic...
10.
Dai L, Li T, Gao Y, Guo Q, Lu J, Liang L, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2008 Jun;
16(6):469-70.
PMID: 18579004
No abstract available.